Combination of recombinant xenogeneic endoglin DNA and protein vaccination enhances anti-tumor effects.

about

Peptide Vaccine Therapy in Colorectal Cancer Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents.

P2860

Q26830336-DB59C3FD-8E2E-43C7-9E6C-3C25F7166D96 Q39365796-F4596511-4223-4A73-B035-40D934FB9DEA

P2860

Combination of recombinant xenogeneic endoglin DNA and protein vaccination enhances anti-tumor effects.

Item

http://www.wikidata.org/entity/Q39508210

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Combination of recombinant xen ...... n enhances anti-tumor effects.

@en

Combination of recombinant xen ...... n enhances anti-tumor effects.

@nl

type

Item

label

Combination of recombinant xen ...... n enhances anti-tumor effects.

@en

Combination of recombinant xen ...... n enhances anti-tumor effects.

@nl

prefLabel

Combination of recombinant xen ...... n enhances anti-tumor effects.

@en

Combination of recombinant xen ...... n enhances anti-tumor effects.

@nl

P1476

Combination of recombinant xen ...... n enhances anti-tumor effects.

@en

P2093

Feng-Ying Huang

http://www.w3.org/2001/XMLSchema#string

Guang-Hong Tan

http://www.w3.org/2001/XMLSchema#string

Hua Wang

http://www.w3.org/2001/XMLSchema#string

Jie Jang

http://www.w3.org/2001/XMLSchema#string

Rui-Zhen Bai

http://www.w3.org/2001/XMLSchema#string

Yue-Nan Li

http://www.w3.org/2001/XMLSchema#string

P2860

Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth

Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice

CD105 is important for angiogenesis: evidence and potential applications

Mechanisms of angiogenesis

What is the evidence that tumors are angiogenesis dependent?

Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen.

Clinical applications of angiogenic growth factors and their inhibitors.

Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1.

P304

423-440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08820130701361103

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17691024

http://www.w3.org/2001/XMLSchema#string

Combination of recombinant xenogeneic endoglin DNA and protein vaccination enhances anti-tumor effects.

about

P2860

P2860

Combination of recombinant xenogeneic endoglin DNA and protein vaccination enhances anti-tumor effects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698